Valente Serafina, Marini Marco, Battistoni Ilaria, Sorini Dini Carlotta, Di Mario Carlo, De Maria Renata, Aspromonte Nadia, Cacciavillani Luisa, Ferraiuolo Giuseppe, Iacoviello Massimo, Casolo Giancarlo, Di Lenarda Andrea, Gulizia Michele Massimo
S.O.D. Interventistica Cardiologica Strutturale, AOU Careggi, Firenze - Area Emergenza-Urgenza ANMCO.
S.O.D. Cardiologia-Emodinamica-UTIC, Dipartimento di Scienze Cardiovascolari, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona - Area Giovani ANMCO.
G Ital Cardiol (Rome). 2017 Oct;18(10):719-726. doi: 10.1714/2790.28261.
Cardiogenic shock (CS) is a rare disease that needs a rapid and multiparameter diagnosis and a timely, aggressive and multidisciplinary goal-oriented treatment. Recently published epidemiological studies and registries underline how SC represents an infrequent clinical entity still burdened by high mortality rates, substantially unchanged over the years. Currently, only few patients with CS are treated with circulatory assistance in dedicated centers. Some consensus documents and expert recommendations emphasize the importance of early diagnosis of CS, immediate pharmacological support, and treatment of precipitating causes, and stress the need for hospitalization in high-volume intensive care centers. The aim of this review is to show the instructions for the creation of a SC network, emphasizing the necessary elements, in agreement with available resources and existing health regulations for giving the same care opportunities to all the patients.
心源性休克（CS）是一种罕见疾病，需要快速进行多参数诊断以及及时、积极且多学科的目标导向治疗。最近发表的流行病学研究和登记数据强调，心源性休克是一种罕见的临床病症，多年来死亡率一直居高不下且基本未变。目前，只有少数心源性休克患者在专门的中心接受循环辅助治疗。一些共识文件和专家建议强调了心源性休克早期诊断、立即给予药物支持以及治疗诱发因素的重要性，并强调需要在大型重症监护中心住院治疗。本综述的目的是展示创建心源性休克网络的指导意见，强调必要要素，同时结合可用资源和现行卫生法规，以便为所有患者提供同等的治疗机会。
